Short communication
Decrease of Virus Receptors during Highly Pathogenic H5N1 Virus Infection in Humans and Other Mammals

https://doi.org/10.1016/j.ajpath.2013.07.004Get rights and content
Under an Elsevier user license
open archive

Highly pathogenic avian influenza H5N1 virus causes a severe, often fatal, pneumonia in humans. The tropism and pathogenesis of highly pathogenic avian influenza H5N1 virus can partly be explained by the presence of H5N1 virus receptors in the human alveoli, which are the site of inflammation during pneumonia. Although studies on the distribution of influenza virus receptors in normal respiratory tract tissues have provided significant insights into the cell tropism and pathogenesis of influenza viruses, the distribution of influenza virus receptors have not been studied during influenza virus infection. Therefore, we studied the distribution of H5N1 virus receptors, by virus and lectin histochemistry, during highly pathogenic avian influenza H5N1 virus infection in alveolar tissues of humans, macaques, ferrets, and cats. In all species, we observed a decrease of H5N1 virus receptors in influenza virus–infected and neighboring cells. The observed decrease of H5N1 virus receptors was associated with the presence of MxA, a known marker for interferon activity. Taken together, our data suggest that the decrease of H5N1 virus receptors might be part of a defense mechanism that limits viral replication in the lower respiratory tract.

Cited by (0)

Supported by the European Commission ANTIGONE grant FP7 278976 and FLUPIG grant FP7-GA258084.

Disclosures: A.D.M.E.O. performs no consultancies with companies on a personal title. Any consultancies performed are through contracts between Erasmus MC and any companies that desire consulting services. A.D.M.E.O. has share certificates in ViroClinics Biosciences B.V. The majority of the shares in ViroClinics Biosciences BV (>75%) are owned by Erasmus MC through its Erasmus MC Holding B.V. To avoid any possible conflict of interest and to safeguard its employees against the possibility of unethical decisions, the Erasmus MC does not allow any of its employees to hold shares in person in any companies that are (partly) owned by Erasmus MC. Any shares provided by such companies to any Erasmus MC employees are held by a Foundation Administration Office. The board of this foundation is appointed by Erasmus MC. The employees receive share certificates of their shares.